Clinical Trials

Showing trials with last updates posted in 2025.

NCT06098079 | RECRUITING | PHASE4
8600 Participants

Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-01-03
Completion: 2029-01-31
Conditions
Obesity
Interventions
DRUG
No Results Yet
NCT06096337 | ACTIVE_NOT_RECRUITING | NA
484 Participants

Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2023-12-28
Completion: 2026-02-03
Conditions
Persistent Atrial Fibrillation
Interventions
DEVICE DRUG
No Results Yet
NCT06091787 | COMPLETED | NA
90 Participants

Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration on Right Lobe Donor Hepatectomy

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2023-09-01
Completion: 2024-11-30
Conditions
Liver Regeneration Ursodeoxycholic Acid Partial Liver Resection
Interventions
DRUG OTHER
No Results Yet
NCT06080789 | RECRUITING | PHASE2
36 Participants

A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-06-28
Completion: 2026-06-30
Conditions
Acute Pancreatitis
Interventions
DRUG
No Results Yet
NCT06080425 | RECRUITING | NA
75 Participants

Promoting Intergenerational Health in Rural Kentuckians With Diabetes (PIHRK'D)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2023-09-01
Completion: 2025-12-31
Conditions
Diabetes Mellitus, Type 2
Interventions
BEHAVIORAL
No Results Yet
NCT06079879 | RECRUITING | PHASE3
340 Participants

A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2023-12-31
Completion: 2027-07-30
Conditions
Essential Thrombocythemia
Interventions
DRUG
No Results Yet
NCT06075576 | COMPLETED
23 Participants

Characterization of the Central and Peripheral Wavefront Aberration Profile in Pediatric Myopic Subjects

Study Type: OBSERVATIONAL
Last Updated: 2025-12-24
Start Date: 2023-11-16
Completion: 2025-08-11
Conditions
Myopia
Interventions
DIAGNOSTIC_TEST
No Results Yet
NCT06075537 | ENROLLING_BY_INVITATION | PHASE2/PHASE3
99 Participants

An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2023-09-20
Completion: 2027-06-30
Conditions
Mucopolysaccharidosis II
Interventions
DRUG
No Results Yet
NCT06074341 | ACTIVE_NOT_RECRUITING | NA
470 Participants

TeleHealth Resources for IndiVidualizEd Goals (THRIVE) in Alcohol Recovery Study

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2023-09-13
Completion: 2028-01-31
Conditions
Alcohol Use Disorder Alcohol Drinking Alcohol-Related Disorders
Interventions
BEHAVIORAL
No Results Yet
NCT06073041 | COMPLETED | NA
20 Participants

Implementing and Evaluating the Integration of Physical Activity Into a Major Health System and Connecting Patients to Physical Activity Programs.

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2023-08-03
Completion: 2023-09-05
Conditions
Chronic Disease Exercise Physical Activity
Interventions
OTHER BEHAVIORAL
No Results Yet
NCT06065462 | RECRUITING | PHASE1/PHASE2
21 Participants

Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2023-11-10
Completion: 2027-10-01
Conditions
Ovarian Clear Cell Carcinoma
Interventions
DRUG
No Results Yet
NCT06052306 | ACTIVE_NOT_RECRUITING | PHASE1
232 Participants
NCT06051617 | RECRUITING | PHASE3
318 Participants

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2023-09-07
Completion: 2030-08-31
Conditions
Primary Biliary Cholangitis
Interventions
DRUG
No Results Yet
NCT06046170 | ACTIVE_NOT_RECRUITING | NA
60 Participants

Adaptation and Feasibility of the Community-Based Anxiety Program Tailored for Autism (CAPTA)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-02-16
Completion: 2026-04-30
Conditions
Anxiety Autism Spectrum Disorder Separation Anxiety Generalized Anxiety Disorder Social Anxiety Disorder of Childhood
Interventions
BEHAVIORAL OTHER
No Results Yet
NCT06044935 | RECRUITING | NA
100 Participants

Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-01-08
Completion: 2026-01-31
Conditions
Overweight Obesity
Interventions
OTHER DIETARY_SUPPLEMENT
No Results Yet
NCT06042725 | RECRUITING | PHASE1
100 Participants

MC210808 Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd), Daratumumab and Dexamethasone (Ven-Dd), or Daratumumab-Lenalidomide-Dexamethasone (Ven-DRd) for the Treatment of Multiple Myeloma

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-03-04
Completion: 2028-12-01
Conditions
Multiple Myeloma
Interventions
PROCEDURE BIOLOGICAL DRUG OTHER
No Results Yet
NCT06040190 | RECRUITING | PHASE4
150 Participants

Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2023-11-01
Completion: 2026-02-01
Conditions
Burning Mouth Syndrome
Interventions
DRUG DIETARY_SUPPLEMENT OTHER RADIATION
No Results Yet
NCT06029517 | ACTIVE_NOT_RECRUITING | NA
48 Participants

A Sugar-Sweetened Beverage Reduction Intervention for Native American Men

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2022-07-20
Completion: 2025-09-15
Conditions
Cardiovascular Disorder Coronary Artery Disease Diabetes Mellitus Obesity-Related Malignant Neoplasm
Interventions
OTHER PROCEDURE
No Results Yet
NCT06022081 | ACTIVE_NOT_RECRUITING | NA
60 Participants

Lung Ultrasound Versus Chest Radiography for Detection of Pneumothorax

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2023-09-27
Completion: 2024-07-23
Conditions
Pneumothorax
Interventions
DIAGNOSTIC_TEST
No Results Yet
NCT06022029 | RECRUITING | PHASE1
168 Participants

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2023-10-13
Completion: 2026-04-30
Conditions
Triple Negative Breast Cancer Diffuse Large B Cell Lymphoma Follicular Lymphoma Lymphoma, Non-Hodgkin Mantle Cell Lymphoma Bladder Cancer Uveal Melanoma, Recurrent Cervix Cancer Carcinoma in Situ Head and Neck Squamous Cell Carcinoma Skin Cancer Metastatic Cancer Tumor, Solid Tumor Recurrence
Interventions
DRUG
No Results Yet
NCT06014086 | ACTIVE_NOT_RECRUITING | PHASE1
30 Participants

Intratumoral PH-762 for Cutaneous Carcinoma

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2023-11-07
Completion: 2026-01-31
Conditions
Malignant Melanoma of Skin Squamous Cell Carcinoma of the Skin Merkel Cell Carcinoma of Skin
Interventions
DRUG
No Results Yet
NCT06009276 | RECRUITING
70 Participants

Associations Between the Microbiome, Skeletal Muscle Perfusion, and Fitness Status

Study Type: OBSERVATIONAL
Last Updated: 2025-12-24
Start Date: 2023-08-30
Completion: 2026-12-31
Conditions
Heart Failure, Diastolic Peripheral Arterial Disease Overweight and Obesity Heart Failure, Systolic
No Results Yet
NCT05996185 | RECRUITING | PHASE2
22 Participants

Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-10-09
Completion: 2026-11-30
Conditions
T Cell Lymphoma T-cell Lymphoma
Interventions
DRUG
No Results Yet
NCT05977322 | TERMINATED | PHASE1
24 Participants

A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2023-10-06
Completion: 2024-12-13
Conditions
Pancreatic Ductal Adenocarcinoma Gastroesophageal Adenocarcinoma Glioblastoma Multiforme
Interventions
DRUG
No Results Yet
NCT05961956 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
5 Participants

Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2023-10-12
Completion: 2026-04-18
Conditions
Degenerative Lumbar Spondylolisthesis
Interventions
DRUG
No Results Yet
NCT05959304 | ACTIVE_NOT_RECRUITING | PHASE4
63 Participants

Post Marketing Study to Evaluate the Safety and Effectiveness of Brolucizumab in Patients With Diabetic Macular Edema.

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-12-11
Completion: 2026-02-28
Conditions
Diabetic Macular Edema
Interventions
DRUG
No Results Yet
NCT05958667 | NOT_YET_RECRUITING | NA
1200 Participants

Quitxt Mobile Text Messaging Cessation Research Study

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2026-01-31
Completion: 2028-08-31
Conditions
Smoking Cessation
Interventions
BEHAVIORAL OTHER
No Results Yet
NCT05947851 | RECRUITING | PHASE3
735 Participants

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2023-08-08
Completion: 2032-06-01
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Chronic Lymphocytic Small-Cell Lymphoma Lymphoma, Small Lymphocytic CLL SLL
Interventions
DRUG BIOLOGICAL
No Results Yet
NCT05943509 | ACTIVE_NOT_RECRUITING | NA
120 Participants

Hearing Program in Primary Care

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-02-15
Completion: 2026-01-15
Conditions
Deafness
Interventions
BEHAVIORAL
No Results Yet
NCT05938153 | COMPLETED
41 Participants

Evaluation of Metabolic Syndrome, Frailty, Locomotive Syndrome, Balance and Physical Fitness in Elderly Individuals

Study Type: OBSERVATIONAL
Last Updated: 2025-12-24
Start Date: 2023-06-01
Completion: 2024-11-01
Conditions
Geriatrics Fragility Locomotor Physical Fitness Balance
Interventions
OTHER
No Results Yet
NCT05937373 | TERMINATED | NA
22 Participants

Perioperative Continuous Glucose Monitoring

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2023-08-04
Completion: 2024-05-21
Conditions
Diabetes Mellitus
Interventions
DEVICE OTHER
NCT05934773 | TERMINATED | NA
5 Participants

Post-Brain Injury Walking and Balance Recovery Program

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2022-08-18
Completion: 2025-04-04
Conditions
Acquired Brain Injury Stroke Traumatic Brain Injury
Interventions
DEVICE
No Results Yet
NCT05934136 | COMPLETED | NA
60 Participants

Brain Health Program for Older Adults With Subjective Cognitive Decline

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-01-16
Completion: 2025-11-07
Conditions
Memory Loss (Excluding Dementia) Healthy Lifestyle Risk Reduction Behavior
Interventions
BEHAVIORAL
No Results Yet
NCT05932914 | NOT_YET_RECRUITING
8 Participants

Liver Biopsy Following Gene Therapy For Hemophilia

Study Type: OBSERVATIONAL
Last Updated: 2025-12-24
Start Date: 2026-01-31
Completion: 2030-01-31
Conditions
Hemophilia A Hemophilia B
Interventions
PROCEDURE
No Results Yet
NCT05929222 | RECRUITING | PHASE3
190 Participants

Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2023-12-14
Completion: 2031-04-30
Conditions
Follicular Lymphoma
Interventions
RADIATION OTHER
No Results Yet
NCT05926297 | COMPLETED | NA
92 Participants

Treatment of Peri-implant Mucositis by Sodium Hypochlorite Gel and Cross-linked Hyaluronic Acid Gel

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2023-06-06
Completion: 2025-07-01
Conditions
Peri-implant Mucositis Mucositis Oral
Interventions
PROCEDURE
No Results Yet
NCT05910528 | ACTIVE_NOT_RECRUITING | PHASE2
21 Participants

Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2023-07-24
Completion: 2030-12-31
Conditions
Crohns Disease
Interventions
DRUG
No Results Yet
NCT05905250 | COMPLETED | NA
155 Participants

mHealth for Young Adult Cancer Survivors

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-03-15
Completion: 2025-02-28
Conditions
Survivorship Cancer Psychological Well-Being
Interventions
BEHAVIORAL
NCT05901649 | ACTIVE_NOT_RECRUITING
503 Participants

A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide

Study Type: OBSERVATIONAL
Last Updated: 2025-12-24
Start Date: 2023-07-05
Completion: 2026-06-05
Conditions
Metastatic Hormone-sensitive Prostate Cancer
Interventions
DRUG
No Results Yet
NCT05887908 | COMPLETED | PHASE3
614 Participants

Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects With Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2023-05-23
Completion: 2024-11-22
Conditions
Complicated Urinary Tract Infection Acute Pyelonephritis cUTI AP
Interventions
DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page